Immunomodulators are associated with a lower risk of first surgery among patients with non-penetrating non-stricturing Crohn's disease

American Journal of Gastroenterology

Volumn 104, Issue 11, 2009, Pages 2754-2759

  Picco, Michael F ^a   Zubiaurre, Ignacio ^a   Adluni, Mohamed ^a   Cangemi, John R ^a   Shelton, Donna ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; AZATHIOPRINE; BUDESONIDE; CORTICOSTEROID; IMMUNOMODULATING AGENT; INFLIXIMAB; MERCAPTOPURINE; MESALAZINE;

ADULT; ARTICLE; COHORT ANALYSIS; COLON DISEASE; CONTROLLED STUDY; CROHN DISEASE; FAMILY HISTORY; FEMALE; FOLLOW UP; HAZARD RATIO; HUMAN; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; SMOKING; SURGICAL TECHNIQUE; TREATMENT DURATION;

ADRENAL CORTEX HORMONES; ADULT; COHORT STUDIES; CONFIDENCE INTERVALS; CROHN DISEASE; DIGESTIVE SYSTEM SURGICAL PROCEDURES; DISEASE PROGRESSION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOLOGIC FACTORS; MALE; MESALAMINE; MIDDLE AGED; PROBABILITY; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME;

EID: 72049087446     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2009.387     Document Type: Article

References (23)

1. Hanauer SB. Top-down vs. step-up approaches in chronic inflammatory bowel disease: presumed innocent or presumed guilty. Nat Clin Pract Gastroenterol Hepatol 2005;2:493.
2. Satsangi J, Silverberg MS, Vermeire S et al. Th e Montreal classification of inflammatory bowel disease: controversies, consensus and implications. Gut 2006;55:749-753 (Pubitemid 43764536)
3. Gasche C, Scholmerich J, Brynskov J et al. A simple classification of Crohn's disease, report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998. Inflamm Bowel Dis 2000;6:8-15.
4. Sachar DB, Bodian CA, Goldstein ES et al. Is perianal Crohn's disease associated with internal fistulization? Am J Gastroenterol 2005;100:1547-1549
5. Louis E, Collard A, Oger AF et al. Behavior of Crohn's disease according to the Vienna classification; changing pattern over the course of the disease. Gut 2001;49:777-782 (Pubitemid 33096034)
6. Cosnes J, Cattan S, Blain A et al. Long term evolution of disease behavior of Crohn's disease. Inflamm Bowel Dis 2002;8:244-250 (Pubitemid 34784976)
7. Veloso FT, Ferreira JT, Barros L et al. Clinical outcome of Crohn's disease: Analysis according to the Vienna classification and clinical activity. In- flamm Bowel Dis 2001;7:306-313 (Pubitemid 33069342)
8. Farmer RG, Whelan G, Fazio VW. Long term follow-up of patterns of Crohn's disease. Relationship of clinical patterns with prognosis. Gastroenterology 1985;88:1818-1822
9. Bernell O, Lapidus A, Hellers G. Risk factors for surgery recurrence in 907 patients with primary ileocecal Crohn's disease. Brit J Surg 2000;87:1697-1701 (Pubitemid 30043937)
10. Cosnes J, Nion-Larmurier I, Beaugerie L et al. Impact of the increasing use of immunosuppressants in Crohn's disease on the need for intestinal surgery. Gut 2005;54:237-241 (Pubitemid 40139240)
11. Jess T, Riis L, Vind I et al. Changes in clinical characteristics, course and prognosis of inflammatory bowel disease during the last 5 decades: A population-based study from Copenhagen, Denmark. Inflamm Bowel Dis 2007;13:481-489 (Pubitemid 46668255)
12. Wolters FL, Russel MG, Sijbrandij J et al. Phenotype at diagnosis predicts recurrence rates in Crohn's disease. Gut 2006;55:1124-1130 (Pubitemid 44085679)
13. Ostenburg LE, van Dullemen HM, te Meerman GJ et al. Clinical outcome of Crohn's disease according to the Vienna Classification: disease location is a useful predictor of disease course. Eur J Gastroenterol Hepatol 2006;18:255-261
14. Heiman TM, Greenstein AJ, Lewis B et al. Comparison of primary and reoperative surgery in patients with Crohn's disease. Ann Surg 1998;227:492-495 (Pubitemid 28363263)
15. Tremaine WJ, Timmons LJ, Loft us EV et al. Age at onset of inflammatory bowel disease and the risk of surgery for non-neoplastic disease. Aliment Pharmacol Th er 2007;25:1435-1441
16. Cosnes J, Carbonnel F, Beaugerie L et al. Effects of cigarette smoking on the long-term course of Crohn's disease. Gastroenterology 1996;110:424-431 (Pubitemid 26043875)
17. Alvarez-Lobos M, Arostegui JI, Sans M et al. Crohn's disease patients carrying Nod 2/CARD 15 gene variants have an increased need for first surgery due to stricturing disease and higher rate of surgical recurrence. Ann Surg 2005;242:693-700. (Pubitemid 41567125)
18. Present DH, Korelitz BI, Wisch N et al. Treatment of Crohn's disease with 6-mercaptopurine. A long-term double randomized double-blind study. N Engl J Med 1980;302:981-987 (Pubitemid 10125406)
19. Vernier-Massouille G, Balde M, Salleron J et al. Natural history of pediatric Crohn's disease; A population based cohort study. Gastroenterology 2008;135:1106-1113
20. Podolsky DK. Inflammatory bowel disease. New Eng J Med 2002;347:417-429
21. Cosnes J, Carbonnel F, Carrat F et al. Respective effects of current and former cigarette smoking on the clinical course of Crohn's disease. Alim Pharmacol Th er 1999;13:1403-1411 (Pubitemid 29516251)
22. D ' Agostino RB. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Statist. Med 1998;17:2265-2281
23. Schwartz DA, Loft us EV, Tremaine WJ et al. Th e natural history of fistulizing Crohn's disease in Olmsted County, Minnesota. Gastroenterology 2002;122:875-880